{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:41Z","timestamp":1786119521279,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1097\/olq.0b013e3181e1a2c5","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T21:36:35Z","timestamp":1280180195000},"page":"706-714","source":"Crossref","is-referenced-by-count":26,"title":["Seroprevalence and Correlates of Human Papillomavirus 16\/18 Seropositivity Among Young Women in Costa Rica"],"prefix":"10.1097","volume":"37","author":[{"given":"Sarah","family":"Coseo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cecilia","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolando","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholom","family":"Wacholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Bougelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen-Jan","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Safaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210213","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States.","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"R2-8-20210213","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1470-2045(05)70086-3","article-title":"WHO International Agency for Research on Cancer Carcinogenicity of human papillomaviruses.","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"R3-8-20210213","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","article-title":"Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.","volume":"87","author":"Ho","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R4-8-20210213","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","article-title":"The carcinogenicity of human papillomavirus types reflects viral evolution.","volume":"337","author":"Schiffman","year":"2005","journal-title":"Virology"},{"key":"R5-8-20210213","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: A worldwide perspective.","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"R6-8-20210213","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.283.1.87","article-title":"HPV DNA testing in cervical cancer screening: Results from women in a high-risk province in Costa Rica.","volume":"283","author":"Schiffman","year":"2000","journal-title":"JAMA"},{"key":"R7-8-20210213","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"R8-8-20210213","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jadohealth.2007.02.015","article-title":"Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant.","volume":"40","author":"Pedersen","year":"2007","journal-title":"J Adolesc Health"},{"key":"R9-8-20210213","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ygyno.2008.02.003","article-title":"Immunobiology of HPV and HPV vaccines.","volume":"109","author":"Stanley","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R10-8-20210213","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ygyno.2008.05.036","article-title":"Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16\/18 vaccine: Improving upon nature.","volume":"110","author":"Schwarz","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R11-8-20210213","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1128\/JCM.40.5.1755-1760.2002","article-title":"Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus.","volume":"40","author":"Studentsov","year":"2002","journal-title":"J Clin Microbiol"},{"key":"R12-8-20210213","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 virus-like particle vaccine among young women with preexisting infection: A randomized trial.","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"key":"R13-8-20210213","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1016\/j.vaccine.2008.07.002","article-title":"Rationale and design of a community-based double-blind randomized trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"key":"R14-8-20210213","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1128\/JCM.00539-06","article-title":"Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.","volume":"44","author":"van Doorn","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R15-8-20210213","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/JCM.02580-06","article-title":"Comparison of the SPF10-LiPA system to the hybrid capture 2 assay for detection of carcinogenic human papillomavirus genotypes among 5683 young women in Guanacaste, Costa Rica.","volume":"45","author":"Safaeian","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R16-8-20210213","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/JCM.34.3.745-747.1996","article-title":"Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas.","volume":"34","author":"Baay","year":"1996","journal-title":"J Clin Microbiol"},{"key":"R17-8-20210213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.4.6.6912","article-title":"Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanated HPV16\/18 cervical cancer vaccine.","volume":"4","author":"Dessy","year":"2008","journal-title":"Hum Vaccin"},{"key":"R18-8-20210213","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial.","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"R19-8-20210213","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1158\/1055-9965.EPI-07-0349","article-title":"Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea.","volume":"16","author":"Clifford","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R20-8-20210213","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1099\/vir.0.18995-0","article-title":"Time trends in incidence and prevalence of human papillomavirus type 6, 11, and 16 infections in Finland.","volume":"84","author":"Laukkanen","year":"2003","journal-title":"J Gen Virol"},{"key":"R21-8-20210213","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.bjc.6601272","article-title":"Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10,000 women in Costa Rica.","volume":"89","author":"Wang","year":"2003","journal-title":"Br J Cancer"},{"key":"R22-8-20210213","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1158\/1055-9965.EPI-07-2796","article-title":"Human papillomavirus infection in Ulaanbaatar, Mongolia: A population-based study.","volume":"17","author":"Dondog","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R23-8-20210213","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1128\/JCM.39.12.4344-4348.2001","article-title":"Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes.","volume":"39","author":"Touze","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R24-8-20210213","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/344354","article-title":"Seroprevalence of human papillomavirus type 16 infection in the United States.","volume":"186","author":"Stone","year":"2002","journal-title":"J Infect Dis"},{"key":"R25-8-20210213","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/tropej\/fmm062","article-title":"Seroprevalence and risk factors of human papillomavirus in Taiwan.","volume":"54","author":"Wang","year":"2007","journal-title":"J Trop Pediatr"},{"key":"R26-8-20210213","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1185\/03007990802068151","article-title":"Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6\/11\/16\/18) vaccine clinical trials.","volume":"24","author":"Paavonen","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"R27-8-20210213","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejogrb.2005.02.001","article-title":"Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil.","volume":"124","author":"Naud","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R28-8-20210213","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<489::AID-IJC1>3.0.CO;2-9","article-title":"A survey of seroprevalence of human papillomavirus types 16, 18, and 33 among children.","volume":"80","author":"af Geijersstam","year":"1999","journal-title":"Int J Cancer"},{"key":"R29-8-20210213","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jmv.20874","article-title":"The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.","volume":"79","author":"Marais","year":"2007","journal-title":"J Med Virol"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007435-201011000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:29:24Z","timestamp":1786040964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007435-201011000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3181e1a2c5","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}